After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
Arrowhead Pharmaceuticals Inc. is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Arrowhead Pharmaceuticals Inc. is $2.89B. A total of 0.81 million shares were traded on the day, compared to an average of 1.25M shares.
In the most recent transaction, Hamilton James C sold 6,000 shares of ARWR for 28.03 per share on Apr 01 ’24. After the transaction, the Chief Discovery/Trans Medicine now owns 204,851 company shares. In a previous transaction on Mar 20 ’24, Lu Hongbo bought 1,000 shares at 27.50 per share. ARWR shares that Director owns now total 33,680.
Among the insiders who bought shares, Lu Hongbo acquired of 1,000 shares on Mar 19 ’24 at a per-share price of $28.00. This resulted in the Director holding 32,680 shares of ARWR after the transaction. In another insider transaction, Lu Hongbo bought 1,000 shares at $27.49 per share on Mar 18 ’24. Company shares held by the Director now total 31,680.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, ARWR has a high of $42.48 and a low of $20.67.
As of this writing, ARWR has an earnings estimate of -$0.16 per share for the current quarter. EPS was calculated based on a consensus of 12.0 estimates, with a high estimate of $3.27 per share and a lower estimate of -$0.95. The company reported an EPS of $0.45 in the last quarter
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. ARWR’s latest balance sheet shows that the firm has $367.79M in Cash & Short Term Investments as of fiscal 2021. There were $25.55M in debt and $146.54M in liabilities at the time. Its Book Value Per Share was $1.49, while its Total Shareholder’s Equity was $408.82M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ARWR is Buy with a score of 4.31.
